Benzinga | Jan 20, 2022 05:06AM EST

Aptorum International Limited Received FDA Orphan Drug Designation Wednesday for Rilpivirine for Treatment of Neuroblastoma

https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=858321